The state of regional therapy in the management of metastatic colorectal cancer to the liver
作者： May Cho , Jun Gong , Marwan Fakih
DOI: 10.1586/14737140.2016.1129277
关键词:
摘要: Colorectal cancer (CRC) is one of the leading causes cancer-related mortality in United States. Most colorectal patients die from advanced disease, and two-thirds CRC deaths are due to liver metastases. Liver resection provides best curative option for with metastases (CRLM), yet only 20% those eligible intent. Loco-regional treatment CRLM may provide additional benefits terms down-staging prolonged hepatic disease control. This review focusses on arterial infusion, radioembolization chemoembolization.
elsevier.com
sci-hub.se 参考文章(121)
Gang Young, Charles Breedis, The blood supply of neoplasms in the liver. American Journal of Pathology. ,vol. 30, pp. 969- 977 ,(1954)
Katuzka Barbery, Govindarajan Narayanan, Rekha Suthar, Gabriella Guerrero, Geetika Arora, Transarterial Chemoembolization Using DEBIRI for Treatment of Hepatic Metastases from Colorectal Cancer Anticancer Research. ,vol. 33, pp. 2077- 2083 ,(2013)
Caterina Accettura, Mario Bezzi, Enrico Cortesi, Andrea Mancuso, Bruno Massidda, Luca Paoluzzi, Rosa Giuliani, Marzia Palma, Fabiana Cecere, Giuliana D'Auria, Hepatic arterial continuous infusion (HACI) of oxaliplatin in patients with unresectable liver metastases from colorectal cancer. Anticancer Research. ,vol. 23, pp. 1917- 1922 ,(2003)
Maurizio Cantore, Francesco Montagnani, Camillo Aliberti, Giammaria Fiorentini, Giorgio Benea, Pier Luigi Ballardini, Andrea Mambrini, TACE of liver metastases from colorectal cancer adopting irinotecan-eluting beads: beneficial effect of palliative intra-arterial lidocaine and post-procedure supportive therapy on the control of side effects. Hepato-gastroenterology. ,vol. 55, pp. 2077- 2082 ,(2008)
Hans Ehrsson, Marko Kornmann, Inger Wallin, Claudia Fester, Erkki Lotspeich, Irene Guthoff, Miriam Schatz, Hepatic artery infusion using oxaliplatin in combination with 5-fluorouracil, folinic acid and mitomycin C: oxaliplatin pharmacokinetics and feasibility. Anticancer Research. ,vol. 23, pp. 5203- 5208 ,(2003)
Nakamori S, Kameyama M, Sasaki Y, Iwanaga T, Imaoka S, Fujita M, Hasegawa Y, Fukuda I, Delayed washout of intratumor blood flow is associated with good response to intraarterial chemoembolization for liver metastasis of colorectal cancer. Surgery. ,vol. 114, pp. 97- 101 ,(1993)
Wei Liu, Qing-Kun Song, Bao-Cai Xing, A systematic review and meta-analysis to reappraise the role of adjuvant hepatic arterial infusion for colorectal cancer liver metastases. International Journal of Colorectal Disease. ,vol. 30, pp. 1091- 1102 ,(2015) , 10.1007/S00384-015-2246-2
William D. Ensminger, Steven Come, Emil Frei, Glenn Steele, Michael Glode, Vic Raso, Andre Rosowsky, David C. Levin, A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil. Cancer Research. ,vol. 38, pp. 3784- 3792 ,(1978)
Daniel T. Chang, Anand Swaminath, Margaret Kozak, Julie Weintraub, Albert C. Koong, John Kim, Rob Dinniwell, James Brierley, Brian D. Kavanagh, Laura A. Dawson, Tracey E. Schefter, Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis. Cancer. ,vol. 117, pp. 4060- 4069 ,(2011) , 10.1002/CNCR.25997
L Lim, P Gibbs, D Yip, JD Shapiro, R Dowling, D Smith, A Little, W Bailey, M Liechtenstein, A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy BMC Cancer. ,vol. 5, pp. 132- 132 ,(2005) , 10.1186/1471-2407-5-132